Exposure-response analysis for nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma (CheckMate 040). - Sangro B; Yau T; El-Khoueiry AB; Kudo M; Shen Y; Tschaika M; Roy A; Feng Y; Gao L; Aras U (Clinical and translational science, 2023)